Trial Profile
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Aripiprazole; Quetiapine; Risperidone
- Indications Autistic disorder; Bipolar disorders; Bipolar I disorders; Mania; Mood disorders; Schizophrenia
- Focus Adverse reactions
- 04 Feb 2016 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov record.
- 09 May 2013 New trial record